Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer
HER2 和 VEGFR 联合抑制可通过 PI3K-AKT 通路协同提高晚期卵巢癌的治疗效果
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:11.4
doi:10.1186/s13046-024-02981-5
Weisong Li #, Kai Zhang #, Wenjun Wang #, Yuanyuan Liu, Jianming Huang, Meihong Zheng, Ling Li, Xinyu Zhang, Minjuan Xu, Guofang Chen, Liefeng Wang, Shuyong Zhang1